| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
HRMY
Harmony Biosciences Holdings
|
Sep 24, 2025 | BUY |
Strong Buy
+39.5% avg upside
13 analysts
|
$50.00
50.29% Upside
|
+12.4% |
|
SLDB
Solid Biosciences
|
Sep 22, 2025 | BUY |
Strong Buy
+92.3% avg upside
23 analysts
|
$16.00
92.14% Upside
|
+33.9% |
|
XENE
Xenon
|
May 13, 2025 | BUY |
Strong Buy
+19.0% avg upside
28 analysts
|
$55.00
3.95% Upside
|
+88.8% |
|
ALKS
Alkermes
|
May 11, 2025 | BUY |
Strong Buy
-17.5% avg upside
34 analysts
|
$43.00
4.32% Downside
|
+13.4% |
|
ACAD
ACADIA Pharmaceuticals
|
Feb 27, 2025 | BUY |
Strong Buy
+66.0% avg upside
42 analysts
|
$28.00
29.44% Upside
|
+27.0% |
|
JAZZ
Jazz Pharmaceuticals
|
Feb 26, 2025 | HOLD |
Strong Buy
-1.8% avg upside
35 analysts
|
$150.00
33.19% Downside
|
+31.1% |
|
AXSM
Axsome Therapeutics
|
Feb 18, 2025 | BUY |
Strong Buy
-10.6% avg upside
28 analysts
|
$153.00
38.96% Downside
|
+44.2% |
|
VNDA
Vanda
|
Feb 14, 2025 | BUY |
Strong Buy
+253.1% avg upside
13 analysts
|
$13.00
124.20% Upside
|
+37.8% |
|
GHRS
GH Research
|
Feb 13, 2025 | BUY |
Strong Buy
+64.5% avg upside
11 analysts
|
$14.00
37.06% Downside
|
+2.7% |
|
DRUG
Bright Minds Biosciences
|
Jan 10, 2025 | BUY |
Strong Buy
+120.9% avg upside
10 analysts
|
— | +123.1% |
|
PRTA
Prothena
|
Sep 30, 2024 | BUY |
Buy
+160.9% avg upside
14 analysts
|
— | -41.7% |
|
VXRT
Vaxart
|
Aug 30, 2024 | HOLD |
Strong Buy
+1311.1% avg upside
8 analysts
|
— | -55.2% |
|
CGTX
Cognition Therapeutics
|
Aug 30, 2024 | HOLD |
Strong Buy
+305.1% avg upside
9 analysts
|
— | +400.0% |
|
BIVI
BioVie
|
Jun 21, 2024 | HOLD |
Buy
+847.0% avg upside
6 analysts
|
— | -78.1% |
|
CPRX
Catalyst Pharma
|
Mar 01, 2024 | BUY |
Strong Buy
-17.0% avg upside
15 analysts
|
$34.00
8.39% Upside
|
+34.6% |
|
CYTK
Cytokinetics
|
Dec 27, 2023 | BUY |
Strong Buy
+8.9% avg upside
36 analysts
|
$101.00
28.12% Upside
|
-43.2% |
|
SEELQ
Seelos Therapeutics
|
Sep 20, 2023 | HOLD |
Buy
+46385614.3% avg upside
10 analysts
|
— | -99.7% |
|
CRNX
Crinetics Pharmaceuticals
|
Sep 11, 2023 | BUY |
Strong Buy
+121.2% avg upside
20 analysts
|
$52.00
44.87% Upside
|
+94.6% |
|
DNLI
Denali Therapeutics
|
Aug 30, 2023 | BUY |
Strong Buy
+60.2% avg upside
24 analysts
|
$85.00
264.60% Upside
|
+4.8% |
|
HELP
Helus Pharma
|
Aug 28, 2023 | BUY |
Strong Buy
+861.2% avg upside
12 analysts
|
$3.00
35.80% Downside
|
· |
|
CMPS
COMPASS Pathways
|
Aug 16, 2023 | BUY |
Strong Buy
+63.7% avg upside
18 analysts
|
$21.00
67.59% Upside
|
-22.9% |
|
CLNN
Clene
|
Aug 15, 2023 | BUY |
Strong Buy
+442.4% avg upside
11 analysts
|
$80.00
1231.06% Upside
|
-67.5% |
|
TSE:CRDL
Cardiol Therapeutics
|
Aug 11, 2023 | BUY |
Strong Buy
+636.1% avg upside
6 analysts
|
$4.24
182.84% Upside
|
· |
|
ATAI
Atai Beckley N.V.
|
Aug 08, 2023 | BUY |
Strong Buy
+230.1% avg upside
16 analysts
|
$11.00
170.96% Upside
|
-25.1% |
|
STOK
Stoke Therapeutics
|
Aug 07, 2023 | BUY |
Strong Buy
+25.1% avg upside
18 analysts
|
$14.00
54.94% Downside
|
+134.4% |
|
DFTX
Definium Therapeutics
|
Aug 04, 2023 | BUY |
Strong Buy
+44.9% avg upside
20 analysts
|
$7.00
71.33% Downside
|
+86.4% |
|
FENC
Fennec Pharmaceuticals
|
Aug 03, 2023 | BUY |
Strong Buy
+78.1% avg upside
9 analysts
|
$16.00
76.53% Upside
|
-28.1% |
|
BHVN
Biohaven Ltd.
|
Aug 01, 2023 | BUY |
Strong Buy
+87.5% avg upside
25 analysts
|
$31.00
128.35% Upside
|
+94.0% |
|
NBIX
Neurocrine
|
Aug 01, 2023 | BUY |
Strong Buy
+7.8% avg upside
37 analysts
|
$135.00
14.72% Downside
|
+48.1% |
|
LUCD
Lucid Diagnostics
|
May 17, 2023 | BUY |
Strong Buy
+350.9% avg upside
8 analysts
|
$4.00
270.45% Upside
|
-40.1% |
|
ORMP
Oramed Pharm
|
Mar 24, 2023 | HOLD |
Strong Buy
+396.3% avg upside
7 analysts
|
— | +35.4% |
|
AVXL
Anavex Life Sciences
|
Dec 06, 2022 | HOLD |
Strong Buy
+782.2% avg upside
9 analysts
|
$11.00
302.95% Upside
|
-4.4% |
|
NVAX
Novavax
|
Jun 24, 2022 | BUY |
Buy
+154.0% avg upside
20 analysts
|
$168.00
1740.14% Upside
|
-87.0% |
|
INO
Inovio Pharmaceuticals
|
May 11, 2022 | BUY |
Buy
+808.5% avg upside
19 analysts
|
$3.00
169.04% Upside
|
-56.9% |
|
VTVT
vTv Therapeutics
|
Feb 18, 2022 | BUY |
Strong Buy
-6.9% avg upside
12 analysts
|
$5.00
85.66% Downside
|
+1.3% |
|
NEUP
Neuphoria Therapeutics
|
Jan 10, 2022 | BUY |
Strong Buy
+365.8% avg upside
6 analysts
|
$52.00
1106.45% Upside
|
-61.6% |
|
FLNA
Filana Therapeutics
|
Jul 15, 2021 | HOLD |
Buy
+2987.5% avg upside
4 analysts
|
$100.00
8096.77% Upside
|
· |
|
OVID
Ovid Therapeutics
|
Apr 19, 2021 | HOLD |
Strong Buy
+108.4% avg upside
17 analysts
|
$4.00
76.21% Upside
|
-14.9% |
|
VYGR
Voyager Therapeutics
|
Dec 23, 2020 | HOLD |
Strong Buy
+284.7% avg upside
23 analysts
|
$10.00
168.80% Upside
|
-65.3% |
|
GERN
Geron
|
May 31, 2020 | BUY |
Strong Buy
+240.0% avg upside
19 analysts
|
$4.00
217.53% Upside
|
-14.8% |
|
HALO
Halozyme
|
May 04, 2020 | BUY |
Strong Buy
-13.7% avg upside
20 analysts
|
$39.00
43.05% Downside
|
+103.2% |
|
TVRD
Tvardi Therapeutics
|
Apr 22, 2020 | BUY |
Buy
+588.1% avg upside
23 analysts
|
$34.00
1192.76% Upside
|
+72.7% |
|
CORT
Corcept Therapeutics
|
Feb 21, 2020 | HOLD |
Buy
-45.6% avg upside
15 analysts
|
$15.00
81.18% Downside
|
+98.2% |
|
ACET
Adicet Bio
|
Sep 09, 2019 | BUY |
Strong Buy
+212.8% avg upside
14 analysts
|
$23.00
184.00% Upside
|
-78.9% |
|
ECOR
Electrocore
|
May 30, 2019 | HOLD |
Strong Buy
+537.6% avg upside
10 analysts
|
— | -52.3% |
|
NTBLQ
Notable Labs
|
Mar 08, 2018 | HOLD |
Buy
+809999900.0% avg upside
12 analysts
|
$4.00
399999900.02% Upside
|
· |
|
SGMO
Sangamo Therapeutics
|
Feb 22, 2018 | BUY |
Buy
+5843.7% avg upside
16 analysts
|
$32.00
18238.07% Upside
|
-65.2% |
|
ALT
Altimmune
|
Oct 09, 2017 | BUY |
Strong Buy
+935.8% avg upside
19 analysts
|
$180.00
6566.67% Upside
|
-94.0% |
|
BCRX
BioCryst
|
Mar 16, 2017 | BUY |
Strong Buy
+103.2% avg upside
24 analysts
|
$13.00
44.63% Upside
|
-39.0% |
|
ARCT
Arcturus Therapeutics
|
Jan 17, 2017 | HOLD |
Buy
+291.8% avg upside
35 analysts
|
$10.50
39.42% Upside
|
+45.3% |
|
INCY
Incyte
|
Aug 01, 2016 | BUY |
Buy
+1.0% avg upside
47 analysts
|
— | +43.1% |
|
TRAW
Traws Pharma
|
Dec 08, 2015 | BUY |
Buy
+3604.6% avg upside
10 analysts
|
$60.00
6956.38% Upside
|
-81.6% |
|
PTN
Palatin Technologies
|
Aug 19, 2015 | BUY |
Strong Buy
+899.8% avg upside
4 analysts
|
$4.00
65.78% Downside
|
-46.4% |
|
TCRT
Alaunos Therapeutics
|
Mar 04, 2014 | HOLD |
Buy
+603.1% avg upside
13 analysts
|
— | +199.8% |
|
OSUR
Orasure Technologies
|
May 16, 2012 | BUY |
Buy
+99.5% avg upside
11 analysts
|
$15.00
253.04% Upside
|
· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.